Radiation-induced Toxicity in Prostate Cancer/ Standard-Follow-Up Program Prostate

Launched by UNIVERSITY MEDICAL CENTER GRONINGEN · Jan 24, 2017

Keywords

ClinConnect Summary

This clinical trial is studying the side effects that men may experience after receiving treatment for prostate cancer, specifically looking at those who have had curative treatment. The researchers want to understand how these side effects develop and change over time. The trial is currently looking for male participants aged between 65 and 74 who have been treated for prostate cancer, especially those with positive lymph nodes, and who are willing to complete surveys about their health and quality of life.

Eligible participants will be those who have received radiation therapy, either after surgery or as part of their treatment plan. If you join the trial, you can expect to fill out questionnaires about any side effects you may experience and how they affect your daily life. This information will help doctors better understand the impact of treatment on patients and improve care for future patients with prostate cancer.

Gender

MALE

Eligibility criteria

• Inclusion Criteria:
• • All curative treated patients with prostatecancer( with positive lymph nodes)
• • All patients who will be treated with RT( including post-operative, adjuvant treatments)
• • Are willing to fill in toxicity and QOL-questionnarys (QLQ-PR25 en de QLQ-C30)
• Exclusion Criteria:
• • Patients who are not willing to fill in toxicity and QOL-questionnarys Patients who will not get RT Non-curative or palliative treated patients (with bone mestasis) Non-prostate cancer-patients